Adverse event monitoring in clinical tri
โ
M.-A. Wallander; P. Lundborg; K. Svรคrdsudd
๐
Article
๐
1992
๐
Springer
๐
English
โ 660 KB
Although most clinical trials encompass aspects of safety, methods for assessing the safety of a drug by recording adverse events have been poorly studied. It has been suggested that adverse events rather than adverse drug reactions should be monitored, since a reliable determination of which events